Molecular determinants for enzalutamide-induced transcription in prostate cancer

Enzalutamide, a second-generation androgen receptor (AR) antagonist, has demonstrated clinical benefit in men with prostate cancer. However, it only provides a temporary response and modest increase in survival, indicating a rapid evolution of resistance. Previous studies suggest that enzalutamide m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Fuwen, Hankey, William, Wu, Dayong, Wang, Hongyan, Somarelli, Jason, Armstrong, Andrew J, Huang, Jiaoti, Chen, Zhong, Wang, Qianben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Gene regulation, Chromatin and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821169/
https://www.ncbi.nlm.nih.gov/pubmed/31501863
http://dx.doi.org/10.1093/nar/gkz790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821169/
https://www.ncbi.nlm.nih.gov/pubmed/31501863
http://dx.doi.org/10.1093/nar/gkz790

Ejemplares similares